Clinical significance of serum S100 in metastatic malignant melanoma
- 31 October 1995
- journal article
- correction
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (11) , 1898-1902
- https://doi.org/10.1016/0959-8049(95)00087-y
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Neuron-specific enolase as a prognostic factor in metastatic malignant melanomaEuropean Journal Of Cancer, 1992
- Neuron specific enolase (NSE) in serum of patients with malignant melanomaCancer Letters, 1990
- S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system.Stroke, 1987
- S100 PROTEIN: A MARKER FOR HUMAN MALIGNANT MELANOMAS?The Lancet, 1981
- Structural Relation of Two S-100 Proteins in Bovine Brain; Subunit Composition of S-100 a ProteinEuropean Journal of Biochemistry, 1981
- S100 protein is present in cultured human malignant melanomasNature, 1980
- The topographical distribution of S‐100 and GFA proteins in the adult rat brain: An immunohistochemical study using horseradish peroxidase‐labelled antibodiesJournal of Comparative Neurology, 1976
- Demonstration of subunits in beef brain acidic protein (S-100)Biochemical and Biophysical Research Communications, 1969
- Differentiated Rat Glial Cell Strain in Tissue CultureScience, 1968
- A soluble protein characteristic of the nervous systemBiochemical and Biophysical Research Communications, 1965